A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations

Archives of Neurology

Volumn 63, Issue 2, 2006, Pages 210-216

  Blindauer, Karen A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; ETILEVODOPA; SELEGILINE; UNCLASSIFIED DRUG;

ACCIDENTAL INJURY; ADULT; AGED; ANGINA PECTORIS; ANXIETY; ARTICLE; BRAIN DISEASE; CANADA; CLINICAL TRIAL; COMPARATIVE STUDY; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG OVERDOSE; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DYSKINESIA; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; HYPERKINESIA; INFECTION; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NAUSEA; OUTCOME ASSESSMENT; PAIN; PARKINSON DISEASE; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP DISORDER; SUSTAINED RELEASE FORMULATION; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR SKILLS DISORDERS; PARKINSON DISEASE; PRODRUGS; REACTION TIME; TREATMENT OUTCOME;

EID: 32944479042     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.2.210     Document Type: Article

References (23)

1. Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesia and motor fluctuations as estimated from the cumulative literature. Mov Disord. 2001;16:448-458.
2. Rascol O, Brooks D, Korczyn A, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med. 2000;342:1484-1491.
3. Poewe W, Wenning G. Levodopa in Parkinson's disease: mechanisms of action and pathophysiology of late failure. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002:104-115.
4. Kurlan R, Rothfield KP, Woodward WR, et al. Erratic gastric emptying of levodopa may cause "random" fluctuations of parkinsonian mobility. Neurology. 1988;38:419-421.
5. Djaldetti R, Melamed E. Levodopa ethylester: a novel rescue therapy for response fluctuations in Parkinson's disease. Ann Neurol. 1996;39:400-404.
6. Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology. 1996;46:1051-1054.
7. Poewe WH. Clinical aspects of motor fluctuations in Parkinson's disease. Neurology. 1994;44:S6-S9.
8. Swope D. Rapid treatment of "wearing off" in Parkinson's disease. Neurology. 2004;62:S27-S31.
9. Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E. Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized crossover study. Clin Neuropharmacol. 2003;26:322-326.
10. Djaldetti R, Inzelberg R, Giladi N, et al. Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease. Mov Disord. 2002;17:297-302.
11. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
12. Hauser RA, Friedlander J, Zesiewicz TA, et al. A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia. Clin Neuropharmacol. 2000;23:75-81.
13. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of subjects for the clinician. J Psychiatr Res. 1975;12:189-198.
14. Goetz CG, Stebbins GT, Blasucci LM, Grobman MD. Efficacy of a patient-training videotape on motor fluctuations for on-off diaries in Parkinson's disease. Mov Disord. 1997;12:1039-1041.
15. Fahn S, Elton R; UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent Developments in Parkinson's Disease 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-163.
16. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, eds. Third Symposium on Parkinson's Disease. Edinburgh, Scotland: Livingstone; 1969:152-157.
17. Nutt JG, Woodward WR. Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients. Neurology. 1986;36:739-744.
18. Gancher ST, Nutt JG, Woodward WR. Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients. Neurology. 1987;37:940-944.
19. Mouradian MM, Juncos JL, Fabbrini G, Schlegel J, Bartko JJ, Chase TN. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, part II. Ann Neurol. 1988;24:372-378.
20. Pappert EJ, Goetz CG, Niederman F, Ling ZD, Stebbins GT, Carvey PM. Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation. Neurology. 1996;47:1493-1495.
21. Nyholm D, Askmark H, Gomes-Trolin C, et al. Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets. Clin Neuropharmacol. 2003;26:156-163.
22. Kurth MC, Tetrud JW, Tanner CM, et al. Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with "on-off" fluctuations. Neurology. 1993;43:1698-1703.
23. Sage JI, Trooskin S, Sonsalla PK, Heikkila R, Duvoisin RC. Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism. Ann Neurol. 1988;24:87-89.